AstraZeneca stock tumbles as Alexion shares soar after companies agree on takeover deal
AstraZeneca has agreed to buy U.S. Alexion Pharmaceuticals for $39 billion, betting on rare diseases and immunology as the British drug...
Full Article
AstraZeneca stock tumbles as Alexion shares soar after companies agree on takeover deal
Upworthy
0 shares
1 views
You might like
Related news coverage
The Alexion Takeover Is a Major Expansion for AstraZeneca. Why the Stock Is Down 7%
The two companies announced on Saturday that they had reached a deal valuing Alexion at $39 billion.
Upworthy